Alonso Krangle LLP offers free lawsuit evaluations to any Fosamax user who suffered a femur fracture that could be associated with long-term use of this drug.
Melville, NY (PRWEB) March 20, 2012
Attorneys Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, are now evaluating potential Fosamax lawsuit claims on behalf of Fosamax users who have suffered atypical femur fractures. In October 2010, the U.S. Food & Drug Administration (FDA) directed the makers of Fosamax and other bisphosphonates used to treat osteoporosis to add information to the “Warnings and Precautions” section of the drugs’ labels describing the risk of atypical thigh fractures associated with long-term use of bisphosphonates. [fda.gov/drugs/drugsafety/ucm229009.htm]
Since then, hundreds of women throughout the country have filed Fosamax femur fracture lawsuits, many of which are pending in a multidistrict litigation in U.S. District Court, District of New Jersey before the Honorable Garrett E. Brown, Jr. (“MDL No. 2243). Additional Fosamax lawsuits, including those alleging the drug caused femur fractures, have been designated a mass tort (In re: Fosamax Litigation - No. 282 NJ. Super. Ct.) in the Superior Court of New Jersey, Law Division, Atlantic County.
Alonso Krangle LLP is currently offering free Fosamax lawsuit evaluations to anyone who experienced a femur fracture while using this drug. To discuss a potential lawsuit claim with one of the experienced and compassionate Fosamax side effects lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com/.
Fosamax Femur Fractures
Fosamax (alendronate sodium) is the most popular bisphosphonate medication in the United States. It was brought to market by Merck in 1995, and generated over $3 billion in annual sales before it became available as a generic in 2008. Other bisphosphonates include Actonel, Aredia, Boniva, Didronel, Reclast, Skelid, and Zometa. Most bisphosphonates are used treat bone disorders, such as osteoporosis and Paget’s disease. However, Aredia and Zometa are used in the treatment of cancer patients. [bloomberg.com/apps/news?pid=newsarchive&sid=abd4hrVfB7q0; fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm101551.htm]
The FDA’s Fosamax femur facture announcement in October 2010 was prompted by a study conducted by the American Society for Bone Mineral Research Task Force of more than 300 women who sustained atypical femur fractures, 94 percent of whom had taken Fosamax or a similar drug for osteoporosis. Most had been on the drugs for five years or more. Last February, a study published in the Journal of the American Medical Association concluded that older women on bisphosphonate therapy for osteoporosis for 5 years or longer had a 274% higher chance of subtrochanteric or femoral shaft fracture. [fda.gov/drugs/drugsafety/ucm229009.htm; jama.ama-assn.org/content/305/8/783]
According to Alonso Krangle LLP, women taking Fosamax or another bisphosphonates should contact their doctor if they develop new hip or thigh pain (commonly described as dull or aching pain). According to the FDA, Fosamax patients often report this pain weeks or months before they experience a femur fracture. [http://www.fda.gov/Drugs/DrugSafety/ucm229009.htm
Fosamax Side Effects Lawsuits
According to Alonso Krangle LLP, roughly 2,000 Fosamax lawsuits alleging the drug caused serious side effects, including atypical femur fractures, are currently pending in the multidistrict litigation now underway in U.S. District Court, District of New Jersey. On February 3, 2012, the U.S. Judicial Panel on Multidistrict Litigation expanded the Fosamax femur fracture litigation to include not only plaintiffs who have taken Fosamax, but those who have taken Fosamax and other bisphosphonates for osteoporosis. [[jpml.uscourts.gov/MDL-2243-Tag-Along_Transfer.pdf]
Another 1,500 Fosamax lawsuits are pending in the state mass tort in New Jersey. The first cases involving atypical femur factures are expected to come to trial in the fall, according to Alonso Krangle LLP. [judiciary.state.nj.us/mass-tort/fosamax/index.htm]
Alonso Krangle LLP offers free lawsuit evaluations to any Fosamax user who suffered a femur fracture that could be associated with long-term use of this drug. To discuss a potential claim with one of the experienced and compassionate Fosamax femur fracture lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.
About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.
For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.
Alonso Krangle LLP
445 Broad Hollow Road
Melville, New York 11747